SCHEMBL23218018

SCHEMBL23218018

CC(C)(C)OC(=O)N(CC=O)c1ccccc1F

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.40
POLB P06746 1/20 0.40
RIPK1 Q13546 2/20 0.35
CTSS P25774 1/20 0.35
CTSK P43235 1/20 0.35
GPR119 Q8TDV5 1/20 0.34
OPRM1 P35372 1/20 0.33
KCNH2 Q12809 1/20 0.33
SIGMAR1 Q99720 1/20 0.33
AKT1 P31749 1/20 0.33
L3MBTL1 Q9Y468 2/20 0.33
TP53 P04637 2/20 0.33
ALDH1A1 P00352 1/20 0.33
HTT P42858 1/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
MAPT P10636 2/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
PTGIR P43119 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23217979 0.88 ALDH1A1 (0.40) LMNAPOLBRIPK1CTSSCTSK
SCHEMBL17102139 0.84 HTR2C (0.37) RIPK1GPR119
SCHEMBL4832911 0.82 LMNA (0.41) LMNAPOLBRIPK1CTSSCTSK
SCHEMBL6822857 0.82 RIPK1 (0.39) LMNAPOLBRIPK1CTSSCTSK
SCHEMBL1974012 0.80 MEN1 (0.46) AKT1L3MBTL1TP53ALDH1A1HTT
SCHEMBL26345840 0.80 CTSS (0.44) LMNAPOLBRIPK1CTSSCTSK
SCHEMBL26345821 0.78 POLB (0.41) LMNAPOLBRIPK1CTSSCTSK
SCHEMBL26345835 0.77 LMNA (0.40) LMNAPOLBRIPK1CTSSCTSK
SCHEMBL3160941 0.77 MT-CO2 (0.38) RIPK1MAPTPTGIR
SCHEMBL30568129 0.76 PAX8 (0.41) RIPK1CTSSCTSKTP53ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022006340-A1 ALK5 INHIBITORS, CONJUGATES, AND USES THEREOF SILVERBACK THERAPEUTICS, INC. (US) 2022-01-06 WO disclosed
WO-2022006340-A1 ALK5 INHIBITORS, CONJUGATES, AND USES THEREOF SILVERBACK THERAPEUTICS, INC. (US) 2022-01-06 WO disclosed
WO-2021072330-A1 GALNAC-TGFBR1 INHIBITOR CONJUGATES FOR THE TREATMENT OF LIVER DISEASES SILVERBACK THERAPEUTICS, INC. (US) 2021-04-15 WO disclosed